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Objective: Although women are reported to be at increased risk of poor outcome after
coronary artery bypass grafting, female gender may simply be a marker of a high-risk
profile. Therefore, the objective of this study was to characterize the difference between
the female and male profiles of patients presenting for coronary artery bypass grafting.
Methods: From January 1993 to June 2002, 15,597 patients underwent isolated
coronary artery bypass grafting at a single institution. Multivariable logistic regres-
sion was used to develop a model of female gender.
Results: Of 15,597 patients, 3596 (23%) were women. Eighteen variables were
predictive of the female gender profile, including shorter stature, increased weight,
more hypertension, insulin-treated diabetes mellitus, heart failure, and higher tri-
glyceride and high-density lipoprotein cholesterol levels. Hematocrit, bilirubin, and
creatinine values were lower in women compared with men.
Conclusions: The preoperative profiles of women and men undergoing coronary
artery bypass grafting are dissimilar. Statistical modeling techniques provide a
unique perspective on the preoperative profile of the female patient, who is known
to be at a higher risk undergoing coronary artery bypass grafting.
When examining gender differences in outcome after cardiacsurgical procedures, women have been typically profiled ashigh-risk primarily because of a disproportionate distribu-tion of preoperative risk factors associated with adverseoutcomes. There are numerous studies that tabulate differ-ences in the gender distribution of preoperative baseline
variables.1-12 This study characterizes the difference between the female and male
profiles of patients presenting for coronary artery bypass grafting (CABG).
Methods
Patient Population and Data Collection
From January 1993 to June 2002, 15,597 patients underwent isolated CABG at the Cleveland
Clinic Foundation; patients undergoing concomitant valvular procedures were excluded. Data
were prospectively collected for 64 preoperative variables, including baseline demographics,
clinical history, laboratory values, and cardiac catheterization findings, and entered into
institutional computer databases by individuals trained in database collection methods.
Institutional review board approval was obtained from the Cleveland Clinic Foundation to
perform research analyses on these institutional databases.
Statistical Methods
The analysis identified a parsimonious set of characteristics that best differentiated men from
women undergoing CABG, thus creating a gender profile.
Preliminary Analysis
Initial exploratory analyses were performed by calculating summary statistics for each
variable. The only variables to have a considerable amount of missing data were triglyceride,
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high-density lipoprotein (HDL), and low-density lipoprotein
(LDL) cholesterol levels, with approximately 44% missing in
each. These variables were examined further, but no obvious
missing patterns were found. Thus, noninformative imputation was
used, and missing value indicators were included in the final
model. Univariable statistics were also initially computed to com-
pare men and women using the Student t test for continuous
variables and the chi-square test or Fisher’s exact test statistics for
categoric variables.
Before modeling the data, continuous and ordinal variables
were plotted against the logit of being female to identify possible
transformations necessary to linearize the relationship.
Multivariable Analysis
Bootstrap aggregation (bagging) was used to identify variables and
their candidate transformations.13 Coronary branches (mid, prox-
imal, and distal) were excluded from the bagging analysis (dis-
cussed next). A total of 200 data sets of 15,597 were randomly
selected with replacement and automatically analyzed by stepwise
regression with an entry significance level of 0.10 and a signifi-
cance level of 0.05 to stay in the model. Variables chosen in at
least 50% of the models were considered for the final parsimonious
model.
Aggregation Step
To account for correlation among covariates, a cluster analysis was
performed by investigating variables that may instinctively cluster
together, such as height, weight, body surface area, and body mass
index. Exploratory analysis was performed within clusters by plots
and intermediate modeling to identify any interactions and distin-
guish which parameters and transformations have the most distinct
relationship with the probability of being female.
Finally, a parsimonious model was determined with the se-
lected covariates and missing value indicators for the variables
where applicable. The model was further reduced by backward
elimination of P values greater than .05. It is worth noting that
although albumin appeared in 85% of the bootstrap models, it did
not remain in the final model. Last, the coronary branches were
successively added, yet none were found to significantly contribute
to the quality of the model. All results were computed using SAS
8.2 software (SAS Institute Inc, Cary, NC).
Results
Baseline Characteristics
A summary of the distribution of baseline characteristics
according to gender is presented in Tables 1 and 2. Of the
15,597 patients, 3596 (23%) were women and 12,001 (77%)
were men. Women were older (Figure 1) and shorter (Figure
2), weighed less (Figure 3), and had a smaller body surface
area and body mass index compared with men. The occur-
rence of many comorbid conditions was more frequent in
women, such as more hypertension and insulin-treated dia-
betes, as well as a history of heart failure, prior stroke, renal
disease, and peripheral vascular disease. Women also had
lower preoperative hematocrit levels, lower calculated red
blood cell mass (Figure 4), less favorable average LDL
cholesterol and triglyceride profiles, and higher HDL cho-
lesterol levels (Figure 5). Preoperative serum creatinine
measurements were lower in women (Figure 6). Compared
with men, women had a more unstable presentation re-
flected by a higher prevalence of unstable angina, preoper-
ative intra-aortic balloon pump usage, and emergent sur-
gery. Women more frequently received beta blockers and
angiotensin-converting enzyme inhibitors. Men had a
higher prevalence of smoking, alcohol use, and abnormal
left ventricular ejection fractions, as well as more extensive
TABLE 1. Baseline continuous variables according to gender
Characteristic
Female Male Student t
test PN Mean (SD) N Mean (SD)
Demographics
Age at surgery (yr) 3596 67 10 12,001 64 10 .01
Height (cm) 3596 159 7.6 12,001 174 8.0 .01
Weight (kg) 3596 73 16 12,001 87 16 .01
Body mass index (kg/m2) 3596 29 6.3 12,001 29 5.1 .01
Body surface area (m2) 3596 1.8 0.2 12,001 2.0 0.2 .01
Preoperative laboratory values
Hematocrit (%) 3596 37 4.4 12,001 41 4.4 .01
Red cell mass estimate (L) 3596 1.5 0.3 12,001 2.2 0.4 .01
Bilirubin (mg/dL) 3302 0.5 0.3 11,220 0.7 0.4 .01
Albumin (g/dL) 3302 3.9 0.5 11,182 4.1 0.5 .01
BUN (mg/dL) 3596 19 11 12,001 19 8.6 .01
Serum creatinine (mg/dL) 3596 1.1 0.8 12,001 1.2 0.8 .01
Triglycerides (mg/dL) 1751 203 168 6988 183 155 .01
HDL cholesterol (mg/dL) 1746 45 14 6978 38 10 .01
LDL cholesterol (mg/dL) 1718 132 47 6884 128 43 .01
HDL, High-density lipoprotein; LDL, low-density lipoprotein; BUN, blood urea nitrogen.
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coronary artery disease. Men also presented more frequently
for coronary reoperations.
Parsimonious Model
The parsimonious analysis identified 18 variables that re-
flected the female profile (Table 3). This parsimonious
model had high discriminatory ability to distinguish females
from males, yielding a c statistic of 0.975. Shorter height,
increased weight, more hypertension, insulin-treated diabe-
tes, and history of heart failure were significantly associated
with the probability of female gender. The profile of women
was further characterized by increased HDL levels, in-
creased triglycerides, lower serum bilirubin, and a reduced
red blood cell mass. In contrast, the male profile was char-
acterized by more smoking, alcohol consumption, reduced
left ventricular ejection fractions, and more extensive left
main and circumflex coronary artery disease.
TABLE 2. Baseline categoric variables according to gender
Characteristic
Female Male Chi-square
test PN % N %
Preoperative medication
ACE inhibitors 1022 28 3042 25 .01
Antiarrhythmics 462 13 1410 12 .08
Beta blockers 2091 58 6539 55 .01
Calcium channel blockers 1218 34 4111 34 .67
Diabetic agent 378 11 1097 9.1 .01
Clinical history
Myocardial infarction 1903 53 6681 56 .01
Chronic obstructive pulmonary disease 298 8.3 742 6.2 .01
Smoking 1581 44 8540 71 .01
Heart failure 827 23 1657 14 .01
Hypertension 2725 76 7612 63 .01
Diabetes: insulin dependent 712 20 1194 10 .01
Diabetes: non-insulin dependent 655 18 2083 17 .24
Stroke 280 7.8 664 5.5 .01
Peripheral vascular disease 568 16 1516 13 .01
Renal disease 42 1.2 94 0.8 .03
Alcohol use 97 2.7 1126 9.4 .01
Atrial fibrillation 184 5.1 571 4.8 .38
Unstable angina 1490 41 4184 35 .01
Preoperative valvular pathology
Aortic valve regurgitation 215 6 543 4.5 .01
Aortic valve stenosis 60 1.7 139 1.2 .02
Mitral valve regurgitation 715 20 1597 13 .01
Coronary artery disease
Any circumflex system disease 2957 83 10534 88 .01
Any Left main disease 1374 38 4930 41 .01
Any LAD system disease 3396 95 11546 97 .01
Any RCA system disease 3144 88 10831 91 .01
Symptoms
NYHA class .01
1 452 13 1722 15
2 1340 40 5439 48
3 548 16 1417 13
4 1035 31 2709 24
Canadian angina class .01
0 79 2.3 258 2.3
1 1069 32 3317 29
2 1541 46 5916 52
3 590 18 1492 13
4 95 2.8 304 2.7
Emergency surgery 143 4.0 324 2.7 .01
Cardiogenic shock 20 0.6 36 0.3 .02
Intra-aortic balloon pump 128 3.6 270 2 .01
Ventricular function
Abnormal left ventricular function 1740 48 6505 54 .01
ACE, Angiotensin-converting enzyme; LAD, left anterior descending; RCA, right coronary artery; NYHA, New York Heart Association.
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Discussion
Gaining insight into poor outcomes after coronary artery
revascularization procedures requires close scrutiny of the
preoperative risk profile in those patients considered highest
risk for the procedures. Female gender has been associated
with increased in-hospital morbidity and mortality after
CABG primarily because of the unfavorable preoperative
risk profile in women. Women are reported to be older and
of smaller stature1-5 and have a higher prevalence of co-
morbidities.1-6 Studies also show that women present with
more advanced symptoms of congestive heart failure de-
spite less extensive coronary artery disease and better pres-
Figure 1. The gender distribution for age in patients undergoing CABG. Women are, on average, older than men.
The numbers above the data points on the plot represent the sample size per bin.
Figure 2. The gender distribution for height. Women are of significantly shorter stature compared with men. The
numbers above the data points on the plot represent the sample size per bin.
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ervation of left ventricular function when compared with
men.2-4,7 The profile of women undergoing CABG surgery
varies among the published investigations because of incon-
sistency in the data collected by the individual studies and
the analysis of the variables.1-12
Variables more commonly prevalent in women were not
necessarily predictive of the female patient. Virtually all
investigations report that, on average, female patients are
significantly older than male patients undergoing CABG
surgery. Although we found the prevalence of advanced age
Figure 3. The distribution of weight demonstrates that women characteristically weigh less than men. The
numbers above the data points on the plot represent the sample size per bin.
Figure 4. A large percentage of women have lower estimated red blood cell mass. The numbers above the data
points on the plot represent the sample size per bin.
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to be greater in women, we did not find advanced age to be
a significant predictor of female gender in the final parsi-
monious model.
The preoperative profile for women is distinct from that
of the male patient population. Our parsimonious model has
high discriminatory ability to distinguish females from
males among the demographic, angiographic, and labora-
tory values from the database. The 18 variables that were
statistically predictive of female gender describe the female
patient’s physiologic “milieu,” reflecting the patient’s car-
diovascular status, organ function, laboratory profile, and
physical stature.
Figure 5. In this study, women had significantly higher HDL levels compared with men. The numbers above the data
points on the plot represent the sample size per bin.
Figure 6. Overall serum creatinine values were lower in women compared with men undergoing CABG. The
numbers above the data points on the plot represent the sample size per bin.
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Prior studies have described greater disabling symptoms
in women despite less extensive coronary artery disease.3,7
We also found that women dominated the New York Heart
Association functional classification 3 and 4 categories;
however, they had better preserved ejection fractions and
less extensive coronary artery disease compared with men.
The final parsimonious model did not identify higher New
York Heart Association classification categories as a signif-
icantly predictive variable for female gender.
In our study, the preoperative lipid profiles for women
were distinctly different from men. Women had higher
triglyceride, HDL, and LDL cholesterol values. Both the
HDL and triglyceride variables were included in the final
parsimonious model as significant predictors of female gen-
der. Kannel and Wilson14 mentioned a metabolic link of
clustered coronary risk factors among women: dyslipide-
mia, hypertension, and glucose intolerance. Data from the
Framingham Heart Study support that 80% of women with
elevated serum cholesterol levels had 1 or more other major
risk factors. An incremental increase in the ratio of total and
HDL cholesterol “steeply” increased the risk of coronary
heart disease–related events.14 Additional laboratory values
that distinguished women from men were lower preopera-
tive serum creatinine and bilirubin measurements and lower
preoperative red blood cell volume and hematocrit values.
Reduced preoperative red blood cell volume measurements
in women may have important implications with regard to
hemodilution from the cardiopulmonary bypass machine
and the subsequent use of red blood cells.
One of the primary limitations of this study is that we can
only comment on predictors of female gender based on our
measured covariates. Unmeasured variables could impact
the final model. Second, our study collected clinical vari-
ables and does not explain the purported causes or mecha-
nism for the progression of coronary artery disease. The
addition of genetic information to further profile patients
may contribute to mechanistic causes in the future. Further-
more, our study was from a single institution and charac-
terizes only those patients with heart disease presenting for
coronary artery revascularization.
Gender deserves specific consideration in the broad
realm of coronary artery disease. Women may have less risk
of developing coronary artery disease earlier in their lives.
Data from the Framingham Heart Study indicate that high
ratios of total and HDL cholesterol, diabetes, and electro-
cardiographic evidence of left ventricular hypertrophy elim-
inate the female advantage.14 The impact of aggressive risk
factor modification programs on perioperative outcome is
unknown. The key to implementing risk factor modification
programs involves an understanding of the high-risk popu-
lation that the programs are designed to target. A preoper-
ative profile of women such as defined by our model can
specifically target patients for intervention.
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